Purchase Order 36C24225P0419
Award Date
1/7/25
Potential Completion Date
4/7/25
Potential Value
$13K
Federal Agency
Veterans Integrated Service Network 2
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Belle Isle, FL 32809, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $12,580.72, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 (VISN 2) to the prime contractor, Walgreens Specialty Pharmacy, LLC (doing business as Walgreens). The contract is for the delivery of the medication Jynarque (tolvaptan), which is used to treat autosomal dominant polycystic kidney disease. This is a firm fixed-price purchase order with a completion date of February 13, 2025. Walgreens Specialty...
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Walgreens Specialty Pharmacy, LLC, a subsidiary of the Walgreens retail pharmacy chain. The contract is for the supply of the medication Jynarque (tolvaptan), which is used to treat autosomal dominant polycystic kidney disease. The contract has a ceiling value of $83,000.32 and a performance period ending on September 30, 2021. The contract is not set aside for any specific business type....
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration, specifically the Veterans Integrated Service Network (VISN) 2, to Walgreens Specialty Pharmacy, LLC. The contract is for the delivery of the medication Jynarque (tolvaptan) 45/15mg tablets, which is used to treat autosomal dominant polycystic kidney disease. The contract has a ceiling value of $13,242.99 and a performance period ending on June 18, 2025. The...
This federal contract award, valued at $12,580.72, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 (VISN 2) to Walgreens Specialty Pharmacy, LLC, a division of the Walgreens retail pharmacy chain. The contract is for the delivery of the specialized pharmaceutical product Jynarque (tolvaptan), which is used to treat autosomal dominant polycystic kidney disease. This is a firm fixed-price purchase order contract with a period of performance ending...
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Walgreens Specialty Pharmacy, LLC, a subsidiary of the Walgreens retail pharmacy chain. The contract, valued at $83,000.32, is for the supply of the pharmaceutical drug JYNARQUE (tolvaptan) to treat autosomal dominant polycystic kidney disease. The contract does not have a set-aside designation and has an ultimate completion date of September 30, 2021. Walgreens...
This federal contract award, valued at $12,580.72, was issued by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 (VISN 2) to Walgreens Specialty Pharmacy, LLC, a division of the broader Walgreens retail pharmacy chain. The contract is a firm fixed price purchase order for the medication Jynarque (tolvaptan), which is used to treat autosomal dominant polycystic kidney disease. This is one of several similar contracts Walgreens Specialty Pharmacy has received from...
This is a firm fixed price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Walgreens Specialty Pharmacy, LLC, a division of the Walgreens retail pharmacy chain. The $12,580.72 contract is for the supply of Jynarque 45mg/15mg tablets, a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease. The contract has a performance period from June 5, 2024 to September 5, 2024 and was not set aside for...
This is a $13,242.99 firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Walgreens Specialty Pharmacy, LLC, a subsidiary of the Walgreens retail pharmacy chain. The contract is for the delivery of the medication Jynarque (tolvaptan) to the VA's Veterans Integrated Service Network 2 (VISN 2). The award has no set-aside designation, indicating it is open to all qualified vendors. The performance period runs from the award date of April 30, 2025 through the...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Walgreens Specialty Pharmacy, LLC, a subsidiary of the Walgreens retail pharmacy chain. The contract, valued at $13,242.99, is for the delivery of the medication Jynarque (tolvaptan) 45mg/15mg tablets to the VA's Veterans Integrated Service Network (VISN) 2. The contract is not set aside for any specific business type, and there are no indications of subcontractors....
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 2 (VISN 2) to Walgreens Specialty Pharmacy, LLC, a subsidiary of the Walgreens retail pharmacy chain. The contract, valued at $13,242.99, is for the emergency procurement of the medication Jynarque (tolvaptan) to support the VA's healthcare services for veterans. The contract has a period of performance through July 7, 2025 and does not have a set-aside designation,...